Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

As of Thursday morning, IDEXX Laboratories shares are down by 0.49%, with a current price of $455.12. This implies that Erickson's 1,544 shares have a value of $597,944.

The Wednesday morning market activity shows IDEXX Laboratories shares down by 0.74%, trading at $460.32. This implies a total value of $4,280,728 for Fennell's 11,242 shares.

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump ...

Q4 2024 Earnings Call Transcript February 3, 2025 Operator: Good morning, and welcome to the IDEXX Laboratories’ Fourth Quarter 2024 Earnings Conference Call. As a reminder, today’s conference is ...

consumers might opt for fewer veterinary visits or choose lower-cost alternatives for pet care. This shift in consumer behavior could result in reduced demand for IDEXX's premium diagnostic ...

The IDEXX Cancer Dx panel has breakthrough cost, performance, and turn-around-time attributes for early-stage cancer diagnostic screening and as an aid-in-diagnosis test, priced for as little as $ ...

Piotr Swat / SOPA Images / LightRocket via Getty Images IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price increases. The veterinary ...

IDEXX Laboratories, Inc. IDXX posted fourth ... The gross margin expanded 144 basis points (bps) to 59.8% despite a 2.2% rise in the cost of revenues. Sales and marketing expenses rose 5.7% ...

Idexx Laboratories posted higher-than-expected fourth-quarter revenue and provided its outlook for 2025. The veterinary technology-and-testing firm logged net income of $216.1 million, or $2.62 a ...